24 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
and Voting
Corporate Governance
Proposal 1 - Election of Directors
Executive Officers
Executive Compensation
Report of the Audit Committee
Certain … promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”), including:
reduced disclosure about our executive compensation arrangements
424B5
PRME
Prime Medicine Inc
16 Feb 24
Prospectus supplement for primary offering
6:17am
disclosure about our executive compensation arrangements;
not being required to hold advisory votes on executive compensation or to obtain stockholder … of Operations” disclosure;
reduced disclosure about our executive compensation arrangements;
not being required to hold advisory votes on executive
424B5
PRME
Prime Medicine Inc
14 Feb 24
Prospectus supplement for primary offering
5:27pm
in our periodic reports and registration statements;
reduced disclosure about our executive compensation arrangements;
not being required to hold … advisory votes on executive compensation or to obtain stockholder approval of any golden parachute arrangements not previously approved
S-3
phkd2o764
3 Nov 23
Shelf registration
5:23pm
DEF 14A
zxlood6n1ywl
28 Apr 23
Definitive proxy
8:34am
10-Q
lhgvwb7hcgxdbrg
14 Nov 22
Quarterly report
4:46pm
424B4
oy4zhuzlgz0p5qda8mbi
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
vdpjoazc4a kltf
13 Oct 22
IPO registration (amended)
10:51am
S-1
rxocq2vw6ga3fwes
23 Sep 22
IPO registration
4:12pm
DRS/A
wu6 5emiml
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
rpkyrcop
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
eiyofwilayfir7hyq2
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
zx3c5 q2nxfce
25 Mar 22
Draft registration statement (amended)
12:00am
DRSLTR
8tkxny
7 Mar 22
Correspondence regarding draft registration statement
12:00am
DRS/A
uqndjwhsvp2a
7 Mar 22
Draft registration statement (amended)
12:00am
UPLOAD
h4d5q
17 Feb 22
Letter from SEC
12:00am